Unravelling sex-and-gender-specific risk factors of hypertension in India: insights from NFHS 5 (2019-21)

被引:0
作者
Patil, Trupti [1 ]
Jana, Arnab [2 ]
Gaurav, Sarthak [3 ]
机构
[1] Indian Inst Technol, Ashank Desai Ctr Policy Studies, Mumbai 400076, India
[2] Indian Inst Technol, Dept Civil Engn, Mumbai 400076, India
[3] Indian Inst Technol, Shailesh J Mehta Sch Management SJMSOM, Mumbai 400076, India
关键词
India; Cardiovascular disease; SDG; 3.4; Hypertension; Risks; Sex-and-gender specific risks; CARDIOVASCULAR-DISEASES; MANIFESTATIONS;
D O I
10.1186/s12982-025-00444-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cardiovascular diseases (CVDs), particularly hypertension, is a predominant contributor to the overall disease burden. While WHO has renewed its commitment to addressing gender disparities, global and national policies, including the Sustainable Development Goals (SDG) 3.4, lack specific targeting of women as a priority population. Hypertension in women remains under-studied, under-recognized, under-diagnosed, and under-treated. Hence, our study examines the hypertension risks among women and men using WHO's causal framework, National Family Health Survey 5 (2019-21), and logistic regression analysis. Our study highlights that behavioural and metabolic risks increase hypertension among both women and men, however few sex-and-gender-specific risks disproportionately impact women, exacerbating hypertension in women than men. The interplay of sex-and-gender-specific risks with underlying, behavioural, and metabolic domains emphasizes the need for tailored gender-responsive health systems to address hypertension burden disparities. Further research should explore the underlying multicausal mechanisms driving these hypertension disparities and develop targeted interventions to address them.
引用
收藏
页数:11
相关论文
共 59 条
  • [1] Empowerment of women in India as different perspectives based on the AHP-TOPSIS inspired multi-criterion decision making method
    Adhikari, Doli
    Gazi, Kamal Hossain
    Giri, Bibhas Chandra
    Azizzadeh, Fariba
    Mondal, Sankar Prasad
    [J]. RESULTS IN CONTROL AND OPTIMIZATION, 2023, 12
  • [2] Allarakha S., 2022, Soc Sci Humanit Open, V6, P100275, DOI [10.1016/j.ssaho.2022.100275, DOI 10.1016/J.SSAHO.2022.100275]
  • [3] Hypertension treatment cascade in India: results from National Noncommunicable Disease Monitoring Survey
    Amarchand, Ritvik
    Kulothungan, Vaitheeswaran
    Krishnan, Anand
    Mathur, Prashant
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2023, 37 (05) : 394 - 404
  • [4] [Anonymous], 2012, A comprehensive global monitoring framework including indicators and a set of voluntary global targets for the prevention and control of noncommunicable diseases
  • [5] [Anonymous], 2008, WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package
  • [6] [Anonymous], 2019, National Family Health Survey -5
  • [7] Bansal Sushil K, 2012, J Cardiovasc Dis Res, V3, P117, DOI 10.4103/0975-3583.95365
  • [8] Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB study
    Bhansali, A.
    Dhandania, V. K.
    Deepa, M.
    Anjana, R. M.
    Joshi, S. R.
    Joshi, P. P.
    Madhu, S. V.
    Rao, P. V.
    Subashini, R.
    Sudha, V.
    Unnikrishnan, R.
    Das, A. K.
    Shukla, D. K.
    Kaur, T.
    Mohan, V.
    Pradeepa, R.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2015, 29 (03) : 204 - 209
  • [9] Bhattacharya S, 2017, 15 Billion People Quest, V43
  • [10] [Cohen A. Europe W.H.O.-R.O.f Europe W.H.O.-R.O.f], 2017, Addressing comorbidity between mental disorders and major noncommunicable diseases: background technical report to support implementation of the WHO European Mental Health Action Plan 2013-2020 and the WHO European Action Plan for the Prevention and Control of Noncommunicable Diseases 2016-2025